Activation of 5-HT(2C) receptors in the dorsal periaqueductal gray increases antinociception in mice exposed to the elevated plus-maze.

Behavioural brain research 20121101

Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.

ACS chemical neuroscience 20120919

A double dissociation in the effects of 5-HT2A and 5-HT2C receptors on the acquisition and expression of conditioned defeat in Syrian hamsters.

Behavioral neuroscience 20120801

Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.

Journal of medicinal chemistry 20120726

Serotonin 5-HT2C receptor-mediated inhibition of the M-current in hypothalamic POMC neurons.

American journal of physiology. Endocrinology and metabolism 20120601

Piperazine compounds as drugs of abuse.

Drug and alcohol dependence 20120501

Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys.

The Journal of pharmacology and experimental therapeutics 20120501

Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.

Psychopharmacology 20120401

Determination of piperazine-type stimulants in human urine by means of microextraction in packed sorbent and high performance liquid chromatography-diode array detection.

Journal of pharmaceutical and biomedical analysis 20120305

Methamphetamine, amphetamine, MDMA ('ecstasy'), MDA and mCPP modulate electrical and cholinergic input in PC12 cells.

Neurotoxicology 20120301

Influence of serotonergic 5-HT2C receptor antagonist mesulergine in the reversal of memory deficits induced by mCPP.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20120201

Rapid determination of piperazine-type stimulants in human urine by microextraction in packed sorbent after method optimization using a multivariate approach.

Journal of chromatography. A 20120127

Estradiol increases the anorexia associated with increased 5-HT(2C) receptor activation in ovariectomized rats.

Physiology & behavior 20120118

Effects of acute tryptophan depletion on prefrontal-amygdala connectivity while viewing facial signals of aggression.

Biological psychiatry 20120101

Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.

Parkinson's disease 20120101

Yohimbine-induced amygdala activation in pathological gamblers: a pilot study.

PloS one 20120101

[Behavioral effects of ketanserine in prenatally stressed female rats].

Eksperimental'naia i klinicheskaia farmakologiia 20120101

Dynamic 5-HT2C receptor editing in a mouse model of obesity.

PloS one 20120101

Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse.

Neurotoxicology 20111201

Safety, tolerability, and pharmacokinetics of once-daily trazodone extended-release caplets in healthy subjects.

International journal of clinical pharmacology and therapeutics 20111201

Differences in serotonin receptor expression in the brainstem may explain the differential ability of a serotonin agonist to block seizure-induced sudden death in DBA/2 vs. DBA/1 mice.

Brain research 20111018

Unique brain areas associated with abstinence control are damaged in multiply detoxified alcoholics.

Biological psychiatry 20110915

Mirtazapine antagonises the subjective, hormonal and neuronal effects of m-chlorophenylpiperazine (mCPP) infusion: a pharmacological-challenge fMRI (phMRI) study.

NeuroImage 20110915

Control of hippocampal theta rhythm by serotonin: role of 5-HT2c receptors.

Neuropharmacology 20110901

Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels.

Neuron 20110811

Desorption atmospheric pressure photoionization-mass spectrometry in routine analysis of confiscated drugs.

Forensic science international 20110715

Chemical profile of meta-chlorophenylpiperazine (m-CPP) in ecstasy tablets by easy ambient sonic-spray ionization, X-ray fluorescence, ion mobility mass spectrometry and NMR.

Analytical and bioanalytical chemistry 20110701

Hypophagic and hypolocomotive effects of metachloro phenyl piperazine in rats treated with theophylline and caffeine.

Pakistan journal of pharmaceutical sciences 20110701

The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results.

Journal of analytical toxicology 20110701

3,4-methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition.

Toxicology letters 20110530

Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats.

European journal of pharmacology 20110520

Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110501

The autonomic stress-induced hyperthermia response is not enhanced by several anxiogenic drugs.

Physiology & behavior 20110110

Separation of positional CPP isomers by chiral HPLC-DAD of seized tablets.

International journal of legal medicine 20110101

Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice.

BMC pharmacology 20110101

[Effects of 5-HT1 and 5-HT2 serotonin receptors on anxiety- and depression-like behavior in female rats].

Eksperimental'naia i klinicheskaia farmakologiia 20110101

Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs.

Drug testing and analysis 20110101

Influence of early stress on social abilities and serotonergic functions across generations in mice.

PloS one 20110101

[Influence of 2-ethyl-6-methyl-3-hydroxypyridine hemisuccinate on cerebral blood perfusion in rats under experimental pathology conditions].

Eksperimental'naia i klinicheskaia farmakologiia 20110101

[Cerebrovascular and antiserotoninergic activity of the combination of tropoxin and mexidol].

Eksperimental'naia i klinicheskaia farmakologiia 20110101

Acute and chronic treatment with serotonin reuptake inhibitors exert opposite effects on respiration in rats: possible implications for panic disorder.

Journal of psychopharmacology (Oxford, England) 20101201

Dose proportionality of once-daily trazodone extended-release caplets under fasting conditions.

Journal of clinical pharmacology 20101201

5-HT2CRs expressed by pro-opiomelanocortin neurons regulate insulin sensitivity in liver.

Nature neuroscience 20101201

Blockade of 5-HT2A/2C-type receptors impairs learning in female rats in the course of estrous cycle.

Bulletin of experimental biology and medicine 20101201

Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability.

Current neuropharmacology 20101201

Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.

Molecular pharmacology 20101101

Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine.

Journal of analytical toxicology 20101101

[Behavioral effects of m-CPP and ketanserine during ovarian cycle in female rats].

Eksperimental'naia i klinicheskaia farmakologiia 20101101

Hypothalamic orexin and pro-opiomelanocortin activities are essential for the anorexic effects of m-chlorophenylpiperazine in mice.

The international journal of neuropsychopharmacology 20101001

Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala.

Progress in neuro-psychopharmacology & biological psychiatry 20101001

5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment.

Journal of neurochemistry 20101001

Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry.

Journal of chromatography. A 20101001

Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.

Journal of analytical toxicology 20101001

mCPP: an undesired addition to the ecstasy market.

Journal of psychopharmacology (Oxford, England) 20100901

[Effect of tropoxin on cerebrovascular effects of meta-chlorophenylpiperazine and serotonin].

Eksperimental'naia i klinicheskaia farmakologiia 20100901

Abstracts of the 5(th) Cachexia Conference, Barcelona, Spain, December 5-8, 2009.

Journal of cachexia, sarcopenia and muscle 20100901

Determining the subjective effects of TFMPP in human males.

Psychopharmacology 20100801

Fear-potentiated startle, but not light-enhanced startle, is enhanced by anxiogenic drugs.

Pharmacology, biochemistry, and behavior 20100701

Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.

Addiction biology 20100701

Comprehensive identification of active compounds in tablets by flow-injection data-dependent tandem mass spectrometry combined with library search.

Forensic science international 20100415

Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.

Regulatory peptides 20100409

Utility of multivariate analysis in support of in vitro metabolite identification studies: retrospective analysis using the antidepressant drug nefazodone.

Xenobiotica; the fate of foreign compounds in biological systems 20100401

Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion.

Behavioural brain research 20100305

The effects of the 5-HT2C agonist m-chlorophenylpiperazine on elite athletes with unexplained underperformance syndrome (overtraining).

British journal of sports medicine 20100301

Acquisition session length modulates consolidation effects produced by 5-HT2C ligands in a mouse autoshaping-operant procedure.

Behavioural pharmacology 20100301

Neuronal correlates and serotonergic modulation of behavioural inhibition and reward in healthy and antisocial individuals.

Journal of psychiatric research 20100201

5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis.

The Journal of pharmacology and experimental therapeutics 20100201

Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents.

Bioorganic & medicinal chemistry letters 20100201

A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants.

Pharmacology, biochemistry, and behavior 20100101

Decreased response inhibition in middle-aged male patients with type 2 diabetes.

BioPsychoSocial medicine 20100101

Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Neuropsychiatric disease and treatment 20100101

Brain serotonin synthesis in adult males characterized by physical aggression during childhood: a 21-year longitudinal study.

PloS one 20100101

Revisiting the role of neurons in neurovascular coupling.

Frontiers in neuroenergetics 20100101

Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.

Neuropsychiatric disease and treatment 20100101

The many faces of trichotillomania.

International journal of trichology 20100101

An overview of Indian research in obsessive compulsive disorder.

Indian journal of psychiatry 20100101

Content of ecstasy in the Netherlands: 1993-2008.

Addiction (Abingdon, England) 20091201

Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo.

British journal of pharmacology 20091101

Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats.

European journal of pharmacology 20091012

Physical binding pocket induction for affinity prediction.

Journal of medicinal chemistry 20091008

Role of spinal serotonergic pathways in sneeze-induced urethral continence reflex in rats.

American journal of physiology. Renal physiology 20091001

Design and synthesis of pyridazinone-based 5-HT(2C) agonists.

Bioorganic & medicinal chemistry letters 20091001

Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.

Neuropharmacology 20090901

Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.

Bioorganic & medicinal chemistry letters 20090901

Serotonin 5-HT2C receptor-independent expression of hypothalamic NOR1, a novel modulator of food intake and energy balance, in mice.

Biochemical and biophysical research communications 20090821

Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.

Psychopharmacology 20090801

Overexpression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity.

The European journal of neuroscience 20090701

Fluvoxamine exerts anorexic effect in 5-HT2C receptor mutant mice with heterozygous mutation of beta-endorphin gene.

The international journal of neuropsychopharmacology 20090501

Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.

Biological psychiatry 20090501

1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.

European journal of pharmacology 20090417

Synergistic actions of apomorphine and m-chlorophenylpiperazine on ejaculation, but not penile erection in rats.

Biomedical research (Tokyo, Japan) 20090401

Behavioral and neurochemical profile of m-CPP following exposure to single restraint stress in rat.

Acta neurologica Belgica 20090301

Subthalamic neurons show increased firing to 5-HT2C receptor activation in 6-hydroxydopamine-lesioned rats.

Brain research 20090223

Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography-mass spectrometry.

Talanta 20090215

Prevalence of ergot derivatives in natural ryegrass pastures: detection and pathogenicity in the horse.

Theriogenology 20090201

Distribution and neurochemical characterization of neurons within the nucleus of the solitary tract responsive to serotonin agonist-induced hypophagia.

Behavioural brain research 20090103

Trazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodone.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

Obsessive-compulsive disorder and related disorders: a comprehensive survey.

Annals of general psychiatry 20090101

Effect of buspirone on thermal sensory and pain thresholds in human volunteers.

BMC clinical pharmacology 20090101

Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery.

PloS one 20090101

Migraine: an overview.

The open neurology journal 20090101

Anti-inflammatory effects of m-chlorophenylpiperazine in brain glia cells.

International immunopharmacology 20081210

5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis.

Neuron 20081126

Dopaminergic modulation of auditory cortex-dependent memory consolidation through mTOR.

Cerebral cortex (New York, N.Y. : 1991) 20081101

Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.

Psychopharmacology 20081101

Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence.

Journal of psychiatric research 20081001

Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.

European journal of pharmacology 20080911

Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory.

Psychopharmacology 20080901

Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.

Journal of psychiatric research 20080901

Taste-dependent sociophobia: when food and company do not mix.

Behavioural brain research 20080822

HPLC analysis of the antidepressant trazodone and its main metabolite m-CPP in human plasma.

Journal of pharmaceutical and biomedical analysis 20080805

High throughput and sensitive determination of trazodone and its primary metabolite, m-chlorophenylpiperazine, in human plasma by liquid chromatography-tandem mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080801

Exercise is associated with reduction in the anxiogenic effect of mCPP on acoustic startle.

Behavioral neuroscience 20080801

5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.

European journal of pharmacology 20080728

Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice.

Biochemical and biophysical research communications 20080718

Behavioral effects of 1-(m-chlorophenyl)piperazine (m-CPP) in a rat model of tardive dyskinesia.

Pakistan journal of pharmaceutical sciences 20080701

Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of 'hallucinogenic designer drugs' in urine of consumers.

Journal of pharmaceutical and biomedical analysis 20080609

Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: effects of GYKI 52466 and its novel analogues.

Psychopharmacology 20080601

5HT2 receptor activation facilitates P2X receptor mediated excitatory neurotransmission to cardiac vagal neurons in the nucleus ambiguus.

Neuropharmacology 20080601

Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.

Gastroenterology 20080601

Acute chlorophenylpiperazine overdose: a case report and review of the literature.

Therapeutic drug monitoring 20080601

Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine.

Drug metabolism and disposition: the biological fate of chemicals 20080501

Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice.

The Journal of pharmacology and experimental therapeutics 20080501

Behavioral characterization of serotonergic activation in the flatworm Planaria.

Behavioural pharmacology 20080501

m-CPP induced hypolocomotion does not interfere in the assessment of memory functions in rats.

Pakistan journal of pharmaceutical sciences 20080401

Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.

Molecular pharmacology 20080301

Single-blind and Double-blind Randomized Controlled Trials of Palmtherapy(R), an Alternative Medical Approach, for Anxiety before Cardiac Catheterization.

Evidence-based complementary and alternative medicine : eCAM 20080301

Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP.

Journal of analytical toxicology 20080301

Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder.

Progress in neuro-psychopharmacology & biological psychiatry 20080215

5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.

Behavioural brain research 20080211

Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.

Pharmacology, biochemistry, and behavior 20080201

Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.

Journal of medicinal chemistry 20080124

5-HT(2C) antagonism blocks blood oxygen level-dependent pharmacological-challenge magnetic resonance imaging signal in rat brain areas related to feeding.

The European journal of neuroscience 20080101

Comparison of electron and chemical ionization modes by validation of a quantitative gas chromatographic-mass spectrometric assay of new generation antidepressants and their active metabolites in plasma.

Journal of chromatography. A 20071228

An antidepressant that extends lifespan in adult Caenorhabditis elegans.

Nature 20071122

Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways.

Cell metabolism 20071107

MDMA-like behavioral effects of N-substituted piperazines in the mouse.

Pharmacology, biochemistry, and behavior 20071101

Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors.

The international journal of neuropsychopharmacology 20071001

Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20071001

Adrenergic and serotoninergic regulation of myocardial contractility in patients with various morphofunctional changes in the heart resulting from chronic heart failure.

Bulletin of experimental biology and medicine 20071001

Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatment.

Neuropsychiatric disease and treatment 20071001

Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors.

Endocrinology 20070901

The chronobiology and neurobiology of winter seasonal affective disorder.

Dialogues in clinical neuroscience 20070901

Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake: use as adulterant of cocaine resulting in drug-drug interactions?

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070815

Trazodone inhibits T-type calcium channels.

Neuropharmacology 20070801

Possible involvement of spinal noradrenergic mechanisms in the antiallodynic effect of intrathecally administered 5-HT2C receptor agonists in the rats with peripheral nerve injury.

European journal of pharmacology 20070712

Amygdala-prefrontal disconnection in borderline personality disorder.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070701

Neurochemical and behavioral effects of m-CPP in a rat model of tardive dyskinesia.

Pakistan journal of pharmaceutical sciences 20070701

5-HT2 modulation of AY-9944 induced atypical absence seizures.

Neuroscience letters 20070511

Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior.

Neuroscience 20070511

Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.

Bioorganic & medicinal chemistry 20070415

High-throughput quantitation of nefazodone and its metabolites in human plasma by high flow direct-injection LC-MS/MS.

Journal of pharmaceutical and biomedical analysis 20070411

Role of pregabalin in the treatment of generalized anxiety disorder.

Neuropsychiatric disease and treatment 20070401

The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.

European journal of pharmacology 20070322

Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptor.

Journal of medicinal chemistry 20070322

Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze.

Behavioural brain research 20070312

5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation.

The Journal of pharmacology and experimental therapeutics 20070301

Effect of meta-chlorophenylpiperazine and cholecystokinin on food intake of Osborne-Mendel and S5B/P1 rats.

Obesity (Silver Spring, Md.) 20070301

Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study.

Neuroscience 20070223

Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test.

Journal of neural transmission (Vienna, Austria : 1996) 20070201

Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.

Neurotoxicity research 20070201

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.

Psychopharmacology 20070101

Carbon dioxide inhalation induces dose-dependent and age-related negative affectivity.

PloS one 20070101

Salicylate-induced tinnitus: molecular mechanisms and modulation by anxiety.

Progress in brain research 20070101

Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.

European journal of pharmacology 20061228

Hyperphagia alters expression of hypothalamic 5-HT2C and 5-HT1B receptor genes and plasma des-acyl ghrelin levels in Ay mice.

Endocrinology 20061201

Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo.

CNS spectrums 20061201

Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls.

Psychiatry research 20061115

[Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors].

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20061101

Role of the 5-HT2C receptor in improving weight-supported stepping in adult rats spinalized as neonates.

Brain research 20060927

The genetic studies of obsessive-compulsive disorder and its future directions.

Yonsei medical journal 20060831

Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence.

Human psychopharmacology 20060801

Functional magnetic resonance imaging and c-Fos mapping in rats following an anorectic dose of m-chlorophenylpiperazine.

NeuroImage 20060701

Effects of soybean food pellets on m-CPP-induced anxiety model of mice.

Biological & pharmaceutical bulletin 20060701

Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line.

The Journal of pharmacology and experimental therapeutics 20060601

Pharmacological characterization of 5-hydroxytryptamine-induced contraction in the chicken gastrointestinal tract.

Autonomic & autacoid pharmacology 20060401

Pharmacological evaluation of the stress-induced social avoidance model of anxiety.

Brain research bulletin 20060331

Childhood sexual abuse in relation to neurobiological challenge tests in patients with borderline personality disorder and normal controls.

Psychiatry research 20060330

A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice.

Biochemical and biophysical research communications 20060317

Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients.

Psychopharmacology 20060301

Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.

Psychopharmacology 20060301

5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder.

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20060301

Pyrrolo(iso)quinoline derivatives as 5-HT(2C) receptor agonists.

Bioorganic & medicinal chemistry letters 20060201

Does meta-chlorophenylpiperazine (mCPP) activate human platelets?

Platelets 20060201

gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation.

Biological psychiatry 20060115

Medial parabrachial nucleus neurons modulate d-fenfluramine-induced anorexia through 5HT2C receptors.

Brain research 20060105

Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors.

Brain research 20060105

Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.

Drug and alcohol dependence 20060104

Effects of mu-CPP and mesulergine on dietary choices in deprived rats: possible mechanisms of their action.

Progress in neuro-psychopharmacology & biological psychiatry 20060101

Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies.

The pharmacogenomics journal 20060101

The C(-1019)G 5-HT1A promoter polymorphism and personality traits: no evidence for significant association in alcoholic patients.

Behavioral and brain functions : BBF 20060101

[Metachlorophenylpiperazine (mCPP): a new designer drug].

Therapie 20060101

Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.

Journal of chromatography. A 20051209

Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval.

Human reproduction (Oxford, England) 20051201

Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice.

Neuropharmacology 20051201

Methylone and mCPP, two new drugs of abuse?

Addiction biology 20051201

Ethanol substitutes for the discriminative stimulus effects of m-chlorophenylpiperazine.

Brain research 20051116

m-Chlorophenylpiperazine exacerbates perception of salicylate-induced tinnitus in rats.

The European journal of neuroscience 20051101

Enhanced 5-HT2C receptor signaling is associated with haloperidol-induced 'early onset' vacuous chewing in rats: implications for antipsychotic drug therapy.

Psychopharmacology 20051001

Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.

Psychopharmacology 20051001

Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.

Clinical and experimental pharmacology & physiology 20051001

Inhibition of serotonin transporters by cocaine and meprylcaine through 5-TH2C receptor stimulation facilitates their seizure activities.

Brain research 20050928

Does the panic attack activate the hypothalamic-pituitary-adrenal axis?

Anais da Academia Brasileira de Ciencias 20050901

The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.

Dialogues in clinical neuroscience 20050901

Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder.

Neuropsychiatric disease and treatment 20050901

Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20050805

Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.

Pharmacology, biochemistry, and behavior 20050701

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.

PLoS medicine 20050701

Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition.

Journal of psychiatry & neuroscience : JPN 20050701

Brain angiotensin and anxiety-related behavior: the transgenic rat TGR(ASrAOGEN)680.

Brain research 20050607

The use of sudden darkness in mice: a behavioural and pharmacological approach.

Psychopharmacology 20050601

Metabolism of designer drugs of abuse.

Current drug metabolism 20050601

Endophenotypes in the personality disorders.

Dialogues in clinical neuroscience 20050601

Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on ethanol discrimination in the rat.

Alcohol (Fayetteville, N.Y.) 20050601

Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology.

Biological psychiatry 20050515

Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding.

Journal of psychopharmacology (Oxford, England) 20050501

Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6.

Psychiatry research 20050430

Effect of the activation of central 5-HT2C receptors by the 5-HT2C agonist mCPP on blood pressure and heart rate in rats.

Brain research 20050408

Measurement and characterization of energy intake in the mouse.

Current protocols in pharmacology 20050401

Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats.

Psychopharmacology 20050301

m-CPP, a 5-HT2C receptor agonist that modifies the perfusion pressure of the hindquarter vascular bed of anesthetized rat.

Pharmacology 20050201

Anxiogenic treatments do not increase fear-potentiated startle in mice.

Biological psychiatry 20050101

Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs.

Current topics in medicinal chemistry 20050101

Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.

Neuroscience 20050101

Pharmacological challenge with a serotonin 1D agonist in alcohol dependence.

BMC psychiatry 20050101

Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task.

Behavioural brain research 20041206

Thermogenic effect of YM348, a novel 5-HT2C-receptor agonist, in rats.

The Journal of pharmacy and pharmacology 20041201

Anxiety-like state associates with taste to produce conditioned taste aversion.

Biological psychiatry 20041201

Behavioral effects of serotonin and serotonin agonists in two crayfish species, Procambarus clarkii and Orconectes rusticus.

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20041201

Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds.

Psychopharmacology 20041101

Neuroimaging and 5-HT2C receptor polymorphism: a HMPAO-SPECT study in healthy male probands using mCPP-challenge of the 5-HT2C receptor.

Pharmacopsychiatry 20041101

Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice.

Psychopharmacology 20041001

Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20041001

Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders.

The international journal of neuropsychopharmacology 20040901

Differential effects of 5-HT1 and 5-HT2 receptor agonists on hindlimb movements in paraplegic mice.

Progress in neuro-psychopharmacology & biological psychiatry 20040901

A 5-HT2C agonist elicits hyperactivity and oral dyskinesia with hypophagia in rabbits.

Physiology & behavior 20040801

Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.

Pharmacology, biochemistry, and behavior 20040801

Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.

Naunyn-Schmiedeberg's archives of pharmacology 20040801

Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.

Pharmacopsychiatry 20040701

Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats.

Pharmacology 20040601

Serotonin function, personality-trait variations, and childhood abuse in women with bulimia-spectrum eating disorders.

The Journal of clinical psychiatry 20040601

New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.

Journal of medicinal chemistry 20040506

Indoline derivatives as 5-HT(2C) receptor agonists.

Bioorganic & medicinal chemistry letters 20040503

mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes.

Neuropharmacology 20040401

Relationship between anorexia and loss of serotonin uptake sites in brain of mice and rats receiving d-norfenfluramine or d-fenfluramine.

Pharmacology, biochemistry, and behavior 20040301

The application of the principles of clinical drug development to pharmacological challenge tests of the serotonergic system.

Journal of psychopharmacology (Oxford, England) 20040301

Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.

Pain 20040301

m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor.

Behavioral neuroscience 20040201

Molecular cloning and pharmacological characterization of the guinea pig 5-HT1E receptor.

European journal of pharmacology 20040126

Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls.

Psychiatry research 20040101

Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution.

Molecular psychiatry 20040101

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.

European journal of pharmacology 20040101

Bulimia nervosa with co-morbid avoidant personality disorder: behavioural characteristics and serotonergic function.

Psychological medicine 20040101

Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.

Neuropsychobiology 20040101

Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity.

Neurotoxicity research 20040101

Substitution profiles of N-methyl-D-aspartate antagonists in ethanol-discriminating inbred mice.

Alcohol (Fayetteville, N.Y.) 20040101

5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.

Experimental neurology 20031201

Depression of mGluR-mediated IPSCs by 5-HT in dopamine neurons of the rat substantia nigra pars compacta.

The European journal of neuroscience 20031101

Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa.

Psychiatry research 20031015

A PET study after treatment with an anxiety-provoking agent, m-chlorophenyl-piperazine, in conscious rhesus monkeys.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20030901

Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.

British journal of pharmacology 20030901

Involvement of 5-HT(2) receptor in imipramine-induced hyperglycemia in mice.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20030901

Central 5-HT2B/2C and 5-HT3 receptor stimulation decreases salt intake in sodium-depleted rats.

Brain research 20030815

Regulation of septo-hippocampal activity by 5-hydroxytryptamine(2C) receptors.

The Journal of pharmacology and experimental therapeutics 20030801

Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety.

Life sciences 20030801

MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys.

Pharmacology, biochemistry, and behavior 20030801

Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze.

European journal of pharmacology 20030725

Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).

Journal of medicinal chemistry 20030703

Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus.

Neuroendocrinology 20030701

m-CPP-induced self-grooming is mediated by 5-HT2C receptors.

Behavioural brain research 20030616

Effects of single and repeated electroconvulsive shock on the social and agonistic behaviour of resident rats.

Neuropharmacology 20030601

Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.

Journal of mass spectrometry : JMS 20030601

Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.

Psychopharmacology 20030501

Experimental anxiety and antiepileptics: the effects of valproate and vigabatrin in the mirrored chamber test.

Methods and findings in experimental and clinical pharmacology 20030501

Effects of m-CPP in altering neuronal function: blocking depolarization in invertebrate motor and sensory neurons but exciting rat dorsal horn neurons.

Brain research 20030418

Serotonin induces tonic firing in layer V pyramidal neurons of rat prefrontal cortex during postnatal development.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20030415

Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation.

Cephalalgia : an international journal of headache 20030301

Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.

Neuropharmacology 20030301

The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study.

Pharmacology, biochemistry, and behavior 20030301

Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs.

Biological psychiatry 20030215

Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra.

Journal of neurochemistry 20030201

Effect of repeated administration of dexfenfluramine on feeding and brain Fos in mice.

Physiology & behavior 20030201

Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101

Pharmacological characterization of 5-HT(1B) receptor-mediated inhibition of local excitatory synaptic transmission in the CA1 region of rat hippocampus.

British journal of pharmacology 20030101

5-HT1B receptor knockout mice show a compensatory reduction in 5-HT2C receptor function.

The European journal of neuroscience 20030101

5-HT2C receptor agonists as potential drugs for the treatment of obesity.

Current topics in medicinal chemistry 20030101

Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone.

Journal of analytical toxicology 20030101

Anxiolytic-like profile of propofol, a general anesthetic, in the plus-maze test in mice.

Polish journal of pharmacology 20030101

Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.

Psychiatry research 20021215

Synthesis and pharmacological evaluation of new arylpiperazines. 3-[4-[4-(3-chlorophenyl)-1-piperazinyl]butyl]-quinazolidin-4-one - a dual serotonin 5-HT(1A)/5-HT(2A) receptor ligand with an anxiolytic-like activity.

Bioorganic & medicinal chemistry 20021201

Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021201

Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies.

Bipolar disorders 20021201

Antidepressants reduce phosphoinositide-specific phospholipase C (PI-PLC) activity and the mRNA and protein expression of selective PLC beta 1 isozyme in rat brain.

Neuropharmacology 20021201

Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?

Cellular and molecular neurobiology 20021201

Neurogenetics of emotional reactivity to stress in animals.

Dialogues in clinical neuroscience 20021201

Sleep-wake effects of meta-chlorophenyl piperazine and mianserin in the behaviorally depressed rat.

European journal of pharmacology 20021122

2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].

The Journal of pharmacology and experimental therapeutics 20021101

5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.

Psychopharmacology 20021101

The effects of gender and gonadal steroids on the neuroendocrine and temperature response to m-chlorophenylpiperazine in leuprolide-induced hypogonadism in women and men.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021101

In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone.

Xenobiotica; the fate of foreign compounds in biological systems 20021101

Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.

Pharmacopsychiatry 20021101

Effects of GABA(A) compounds on mCPP drug discrimination in rats.

Life sciences 20021018

mCPP-induced hypophagia in rats is unaffected by the profile of dietary unsaturated fatty acids.

Pharmacology, biochemistry, and behavior 20021001

p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.

Journal of neurochemistry 20020901

Are there anxious genes?

Dialogues in clinical neuroscience 20020901

5-HT(2C) receptor activation by m-chlorophenylpiperazine detected in humans with fMRI.

Neuroreport 20020827

Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients.

Therapeutic drug monitoring 20020801

Metachlorophenylpiperazine (m-CPP) induced intracavernous pressure responses in anaesthetized rats.

International journal of impotence research 20020801

The effects of serotonin agonists on the hypothalamic regulation of sexual receptivity in Syrian hamsters.

Hormones and behavior 20020801

Central administration of mCPP, a serotonin 5-HT(2B/2C) agonist, decreases water intake in rats.

Pharmacology, biochemistry, and behavior 20020701

Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression.

Archives of general psychiatry 20020701

Therapeutic and adverse actions of serotonin transporter substrates.

Pharmacology & therapeutics 20020701

Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.

Psychopharmacology 20020601

Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause.

Dialogues in clinical neuroscience 20020601

Gonadal steroids, brain, and behavior: role of context.

Dialogues in clinical neuroscience 20020601

Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.

Psychopharmacology 20020501

Antinociceptive role of 5-HT1A receptors in rat spinal cord.

British journal of anaesthesia 20020501

Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine.

Synapse (New York, N.Y.) 20020401

Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymes.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020401

Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.

Pharmacology, biochemistry, and behavior 20020401

Alteration in 5-hydroxytryptamine agonist-induced behaviour following a corticosterone implant in adult rats.

Pharmacology, biochemistry, and behavior 20020401

Serotonin releasing agents. Neurochemical, therapeutic and adverse effects.

Pharmacology, biochemistry, and behavior 20020401

The nature of the acetylcholine and 5-hydroxytryptamine receptors in buccal smooth muscle of the pest slug Deroceras reticulatum.

Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 20020401

Role of 5-hT2C receptors in the hypophagic effect of m-CPP, ORG 37684 and CP-94,253 in the rat.

Progress in neuro-psychopharmacology & biological psychiatry 20020401

The atypical 5-HT2 receptor mediating tachycardia in pithed rats: pharmacological correlation with the 5-HT2A receptor subtype.

British journal of pharmacology 20020301

Saccadic peak velocity and EEG as end-points for a serotonergic challenge test.

Human psychopharmacology 20020301

Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.

Neuropharmacology 20020201

Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration.

Psychopharmacology 20020201

Evaluation of isotryptamine derivatives at 5-HT(2) serotonin receptors.

Bioorganic & medicinal chemistry letters 20020121

Perturbations of plasma cortisol and DHEA-S following discontinuation of cocaine use in cocaine addicts.

Psychoneuroendocrinology 20020101

Psychomotor slowing, neuroendocrine responses, and behavioral changes after oral administration of meta-chlorophenylpiperazine in normal volunteers.

Psychiatry research 20011231

The subjective effects of MDMA and mCPP in moderate MDMA users.

Drug and alcohol dependence 20011201

The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.

Journal of clinical psychopharmacology 20011201

The 5-HT2C/2B receptor agonist m-chlorophenylpiperazine (mCPP) inhibits 2-deoxy-D-glucose (2-DG)-induced hyperphagia in rats.

Biological & pharmaceutical bulletin 20011201

Effects of serotonin and serotonin analogs on posture and agonistic behavior in crayfish.

Journal of comparative physiology. A, Sensory, neural, and behavioral physiology 20011201

Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.

The international journal of neuropsychopharmacology 20011201

m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors.

Behavioural pharmacology 20011201

Evaluation of the absorption, excretion and metabolism of [14C] etoperidone in man.

Xenobiotica; the fate of foreign compounds in biological systems 20011101

Altered responsiveness to 5-HT at the crayfish neuromuscular junction due to chronic p-CPA and m-CPP treatment.

Brain research 20011019

Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa.

Archives of general psychiatry 20010901

Mapping of brain activation in response to pharmacological agents using fMRI in the rat.

Magnetic resonance imaging 20010901

Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells.

Biochemical pharmacology 20010815

Self-destructiveness and serotonin function in bulimia nervosa.

Psychiatry research 20010805

Pedophilia is accompanied by increased plasma concentrations of catecholamines, in particular epinephrine.

Psychiatry research 20010805

Tryptophan hydroxylase gene and major psychoses.

Psychiatry research 20010805

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety.

Neuropharmacology 20010801

Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration.

The International journal of eating disorders 20010701

Effect of a low tryptophan diet on the prolactin responses to the 5-HT2A agonist DOI in the rat.

Pharmacopsychiatry 20010701

The serotonergic 5-HT(2C) agonist m-chlorophenylpiperazine increases weight-supported locomotion without development of tolerance in rats with spinal transections.

Experimental neurology 20010601

A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation.

Psychopharmacology 20010601

1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010501

Dissociation of systemic and hippocampal modulation of rat locomotor activity by 5-HT(2C) receptors.

Neuroscience research 20010501

Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20010501

Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome.

Psychological medicine 20010501

Effects of genetic polymorphism of CYP1A2 inducibility on the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patients.

Pharmacology & toxicology 20010501

Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.

Psychopharmacology 20010501

Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.

Journal of psychopharmacology (Oxford, England) 20010301

Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.

Psychoneuroendocrinology 20010201

Increased m-CPP-induced oral dyskinesia after lesion of serotonergic neurons.

Pharmacology, biochemistry, and behavior 20010201

Investigations into migraine pathogenesis: time course for effects of m-CPP, BW723C86 or glyceryl trinitrate on appearance of Fos-like immunoreactivity in rat trigeminal nucleus caudalis (TNC).

Cephalalgia : an international journal of headache 20010201

Low versus standard dose mCPP challenge in obsessive-compulsive patients.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010101

Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010101

Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa.

Psychological medicine 20010101

Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.

Psychopharmacology 20010101

m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors.

Neuroscience 20010101

Inhibition of K(+)-evoked release of rat striatal 5-hydroxytryptamine by an atypical antidepressant: trazodone.

Neuropsychobiology 20010101

Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists.

Pharmacology, biochemistry, and behavior 20010101

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.

Circulation 20001205

Cloning, expression, and characterization of ferret 5-HT(3) receptor subunit.

European journal of pharmacology 20000707

Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.

Synapse (New York, N.Y.) 20000201

Serotonin(2C) receptors appear to mediate genetic sensitivity to cocaine-induced convulsions.

Psychopharmacology 19991001

Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions.

Psychopharmacology 19990701

High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.

Journal of neurochemistry 19990501

Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.

Naunyn-Schmiedeberg's archives of pharmacology 19990101

Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources.

Drug metabolism and disposition: the biological fate of chemicals 19980601

[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.

Naunyn-Schmiedeberg's archives of pharmacology 19980101

Effect of fenfluramine challenge on cocaine craving in addicted male users.

The American journal on addictions 19980101

The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.

European journal of pharmacology 19970501

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.

Neuropharmacology 19970101

Bupropion plasma levels and CYP2D6 phenotype.

Therapeutic drug monitoring 19961001

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.

British journal of pharmacology 19960201

Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.

Biochemical pharmacology 19960112

Post-synaptic 5-HT1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats.

Psychopharmacology 19950801

Trazodone treatment increases plasma prolactin concentrations in depressed patients.

International clinical psychopharmacology 19950601

Penile erection and yawning induced by 5-HT1C receptor agonists in male rats: relationship with dopaminergic and oxytocinergic transmission.

European journal of pharmacology 19940811

Central action of glaucine in rodents.

Acta poloniae pharmaceutica 19940101

Prolonged penile erections induced by hydroxyzine: possible mechanism of action.

Neuropsychobiology 19940101

d-Fenfluramine- and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors.

European journal of pharmacology 19930921

Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.

The Journal of biological chemistry 19930825

Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

Molecular pharmacology 19930301

Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.

Molecular pharmacology 19930301

Trazodone induction of migraine headache through mCPP.

The American journal of psychiatry 19920501

Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.

Polish journal of pharmacology and pharmacy 19920101

Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.

Molecular pharmacology 19910801

A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease.

Biological psychiatry 19910715

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.

Archives of general psychiatry 19880201

Central action of ipsapirone, a new anxiolytic drug, on serotoninergic, noradrenergic and dopaminergic functions.

Journal of neural transmission 19870101

Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.

Polish journal of pharmacology and pharmacy 19850101

1-m-Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazole.

The Journal of pharmacy and pharmacology 19821001